Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Holding(s) in Company

May 1, 2024
RNS Number : 8938M Renalytix PLC 01 May 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares

Form 8.3 - Renalytix plc

May 1, 2024
RNS Number : 8811M NR Holdings Limited 01 May 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: NR

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 1, 2024
RNS Number : 7915M Stifel Nicolaus Europe Limited 01 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Form 8 (DD) - Renalytix Plc

April 30, 2024
RNS Number : 6913M Harwood Capital LLP 30 April 2024   FORM 8 (DD)   PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")   1.         KEY

Form 8 (DD) - Renalytix Plc - Replacement

April 30, 2024
RNS Number : 6762M Harwood Capital LLP 30 April 2024       AMENDMENT: THIS FORM REPLACES RNS NUMBER 9333G, ANNOUNCED ON 14 MARCH 2024 AT 15:38. CHANGE MADE TO SECTION 2b.     AMENDMENT: PLEASE DISREGARD THE RNS RELEASED ON 15 MARCH 2024 AT 12:05, RNS NUMBER 0829H,       FORM 8 (DD)   PUBLIC DEALING

Holding(s) in Company

April 30, 2024
RNS Number : 4878M Renalytix PLC 30 April 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)   i 1a. Identity of the issuer or the underlying issuer of existing

Form 8.3 - Renalytix plc

April 29, 2024
RNS Number : 4647M Renalytix PLC 29 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: Icahn

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 29, 2024
RNS Number : 3854M Stifel Nicolaus Europe Limited 29 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Admission of the First Tranche Placing Shares

April 29, 2024
RNS Number : 2850M Renalytix PLC 29 April 2024   Renalytix plc ("Renalytix" or the "Company")   Admission of the First Tranche Placing Shares   LONDON and SALT LAKE CITY -   29 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   confirms that, further to the announcements made on 12 March

Holding(s) in Company

April 26, 2024
RNS Number : 2943M Renalytix PLC 26 April 2024   S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares: Renalytix PLC 1b. Please indicate if the issuer is a non- UK issuer    (please mark with an "X"
Displaying 31 - 40 of 541